JSR
JSR works with startups mainly through JSR Active Innovation Fund, a wholly owned investment subsidiary launched in October 2019 with an initial 3 billion yen (planned up to 10 billion yen) for startups worldwide, first in digital technology and later also in technologies that address social issues. Portfolio examples include semiconductor film maker Gaianixx and AI medical device maker Aillis. JSR also bought the EUV resist startup Inpria for USD 514 million in 2021, ran a separate corporate venture fund at JSR Life Sciences from 2021, and signs joint research agreements with university spin-offs.
Profile details for verified innovation managers
This profile also covers 2 programs with areas of interest and how to apply, 5 collaborations, focus areas, how they work with partners, sourced facts, news. The details are visible to signed-in members who are verified as innovation managers.